Cardiovascular indication (Medicare Part D or commercial) Wegovy is FDA-approved for cardiovascular risk reduction in adults with established CVD who are overweight or obese
Wegovy HD may also cause dysesthesia, an unusual skin sensation such as burning, tingling, pins-and-needles, or increased skin sensitivity
They work best when prescribed thoughtfully, monitored carefully, and used inside a broader plan
The mechanisms underlying these effects are particularly intriguing
[17] [18] The pathophysiology of endometriosis is multifactorial, involving retrograde menstruation, genetic predisposition, immune dysfunction, and inflammatory processes
Youre transitioning into a more durable weight-loss solution This includes bariatric surgery, which offers significantly more durable, long-term results than GLP-1 medications alone